IL86602A - 3,4-dihydro-3-oxo-n-aryl-2h-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-caroxamide-1,1-dioxides and pharmaceutical compositions containing them - Google Patents

3,4-dihydro-3-oxo-n-aryl-2h-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-caroxamide-1,1-dioxides and pharmaceutical compositions containing them

Info

Publication number
IL86602A
IL86602A IL86602A IL8660288A IL86602A IL 86602 A IL86602 A IL 86602A IL 86602 A IL86602 A IL 86602A IL 8660288 A IL8660288 A IL 8660288A IL 86602 A IL86602 A IL 86602A
Authority
IL
Israel
Prior art keywords
thiazine
dihydro
oxo
caroxamide
dioxides
Prior art date
Application number
IL86602A
Other languages
English (en)
Other versions
IL86602A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL86602A0 publication Critical patent/IL86602A0/xx
Publication of IL86602A publication Critical patent/IL86602A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL86602A 1987-06-10 1988-06-02 3,4-dihydro-3-oxo-n-aryl-2h-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-caroxamide-1,1-dioxides and pharmaceutical compositions containing them IL86602A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (2)

Publication Number Publication Date
IL86602A0 IL86602A0 (en) 1988-11-30
IL86602A true IL86602A (en) 1992-06-21

Family

ID=55448100

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86602A IL86602A (en) 1987-06-10 1988-06-02 3,4-dihydro-3-oxo-n-aryl-2h-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-caroxamide-1,1-dioxides and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US4914101A (pl)
EP (1) EP0294994B1 (pl)
JP (1) JPH078874B2 (pl)
KR (1) KR900006758B1 (pl)
CN (1) CN1019576B (pl)
AT (1) ATE105561T1 (pl)
AU (1) AU593743B2 (pl)
CA (1) CA1300625C (pl)
CZ (1) CZ281857B6 (pl)
DD (1) DD281602A5 (pl)
DE (1) DE3889497T2 (pl)
DK (1) DK313388A (pl)
EG (1) EG18525A (pl)
ES (1) ES2051846T3 (pl)
FI (1) FI89802C (pl)
HU (1) HU203762B (pl)
IE (1) IE63214B1 (pl)
IL (1) IL86602A (pl)
MX (1) MX174093B (pl)
MY (1) MY103572A (pl)
NO (2) NO176277C (pl)
NZ (1) NZ224956A (pl)
PH (1) PH25187A (pl)
PL (1) PL158994B1 (pl)
PT (1) PT87678B (pl)
WO (1) WO1988009793A1 (pl)
YU (1) YU46767B (pl)
ZA (1) ZA884115B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455830B1 (en) * 1989-11-30 1996-06-26 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) * 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives

Also Published As

Publication number Publication date
JPH078874B2 (ja) 1995-02-01
IE63214B1 (en) 1995-04-05
ES2051846T3 (es) 1994-07-01
IE881733L (en) 1988-12-10
ZA884115B (en) 1990-02-28
NO890531L (no) 1989-02-08
MX11827A (es) 1993-04-01
CN1019576B (zh) 1992-12-23
EG18525A (en) 1994-04-30
NO922636L (no) 1989-02-08
PL272928A1 (en) 1989-07-10
AU593743B2 (en) 1990-02-15
KR890000500A (ko) 1989-03-15
US4914101A (en) 1990-04-03
KR900006758B1 (ko) 1990-09-20
EP0294994A1 (en) 1988-12-14
DD281602A5 (de) 1990-08-15
NO922636D0 (no) 1992-07-03
PL158994B1 (pl) 1992-10-30
FI890620A7 (fi) 1989-02-09
NO890531D0 (no) 1989-02-08
JPS6413093A (en) 1989-01-17
HU203762B (en) 1991-09-30
DK313388A (da) 1988-12-11
CN88103539A (zh) 1988-12-28
AU1753588A (en) 1988-12-15
HUT54376A (en) 1991-02-28
CZ281857B6 (cs) 1997-03-12
YU111988A (en) 1989-12-31
EP0294994B1 (en) 1994-05-11
YU46767B (sh) 1994-05-10
FI89802C (fi) 1993-11-25
MX174093B (es) 1994-04-21
CA1300625C (en) 1992-05-12
PH25187A (en) 1991-03-27
NO176277B (no) 1994-11-28
FI89802B (fi) 1993-08-13
PT87678A (pt) 1988-07-01
DK313388D0 (da) 1988-06-09
PT87678B (pt) 1992-10-30
NO176277C (no) 1995-03-08
DE3889497D1 (de) 1994-06-16
NZ224956A (en) 1990-07-26
ATE105561T1 (de) 1994-05-15
FI890620A0 (fi) 1989-02-09
MY103572A (en) 1993-08-28
DE3889497T2 (de) 1994-08-25
WO1988009793A1 (en) 1988-12-15
IL86602A0 (en) 1988-11-30
CZ392588A3 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
AU7579094A (en) Methods for the treatment of peri-menopausal syndrome
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
IL71545A0 (en) Naphthoquinone derivatives,their preparation and pharmaceutical compositions containing them
ES8601978A1 (es) Procedimiento para preparar derivados de isoquinoleina
PH25187A (en) 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-(1)benzothieno (3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides, pharmaceutical compositions containing the same and method of use thereof
IL117150A (en) Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
ATE71944T1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
HK45483A (en) Medicaments for treating hypertension
IL113744A0 (en) 3-Cephem derivatives and their preparation
AU1065788A (en) Dissolved composition of (benzo-1,2,4-thiadiazine)-1,1-dioxide
IL61911A0 (en) 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
ES8605269A1 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central
ES8604150A1 (es) Un procedimiento para la preparacion de medicamentos a base de derivados de la 1,4-dihidropiridina
AU4816496A (en) New thiophene compounds, process for the preparation thereof, and pharmaceutical compositions containing them
EP0055907A3 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
JPS5430163A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts
IL61476A (en) Muscle relaxant pharmaceutical compositions containing 5-(optionally substituted phenyl)-6h-1,3,4-thiadiazine-2-amines,some new compounds of this type and process for preparing them

Legal Events

Date Code Title Description
RH Patent void